$NWBO Stock Northwest Biotherapeutics (NWBO, $0.24) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 20, 2025

#Biotechnology, #TechnicalAnalysis, #MACD, #Bullish, #OTCStocks, #SmallCap This is a Bullish indicator signaling NWBO's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 46 similar cases where NWBO's MACD histogram became positive, and 34 of them led to…

https://stocktradingde.wordpress.com/2025/11/25/nwbo-stock-northwest-biotherapeutics-nwbo-0-24-moving-average-convergence-divergence-macd-histogram-turned-positive-on-november-20-2025/

$NWBO Stock Northwest Biotherapeutics (NWBO, $0.24) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 20, 2025

#Biotechnology, #TechnicalAnalysis, #MACD, #Bullish, #OTCStocks, #SmallCap This is a Bullish indicator signaling NWBO’s price could rise from here. Traders may e…

TradeNovaAI

3 ASX Small-Cap Stocks with Strong Growth Potential Identified by Experts

Macquarie has highlighted three ASX small-cap stocks that have delivered impressive year-to-date performance and are expected to continue outperforming the broader market. These stocks are Aussie Broadband, Superloop, and SiteMinder. Aussie Broadband, with a 56% rise in its share price this year, ha... [More info]

KCGI Asset Management has launched its first equity target maturity fund focused on South Korean small-cap stocks, aiming for a 12% return and capping fundraising at 30 billion won ($21.7 million) to address market liquidity.
#YonhapInfomax
#KCGIAssetManagement #SmallCap #TargetMaturityFund #12PercentReturn #KOSDAQ
#Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=80623
KCGI Asset Management Launches First Equity Target Maturity Fund Aiming for 12% Returns in Small Caps

KCGI Asset Management has launched its first equity target maturity fund focused on South Korean small-cap stocks, aiming for a 12% return and capping fundraising at 30 billion won ($21.7 million) to address market liquidity.

Yonhap Infomax

Der Wohlfühlwert mit ambitionierten Zielen bis 2030

Die Aktie gehört zu den Titeln in meinem Depot, denen ich sehr wenig Aufmerksamkeit schenken muss. Ein Management, das weiß was es tut und keine Risiken eingeht. Dazu ein Geschäftsmodell, das auf Langfristigkeit ausgerichtet ist.

Dazu eine Transparenz, die ihresgleichen sucht. Der CEO beantwortet Fragen persönlich und die Hauptversammlung wird als Livestream bei YouTube übertragen und alle Zuschauer können Fragen stellen.

Und zusätzlich ist dieser Wohlfühlwert auch noch gut für mein Girokonto. Denn seit 10 Jahren steigen die Dividenden kontinuierlich und es ist kein Ende in Sicht.

Kein Wunder also, dass ich noch mal nachgekauft habe und so meinen Anteil weiter in Richtung meines Zielwerts geschraubt habe. Alle Details zum Nachkauf, zur Dividendenzahlung und meine Einschätzung zu den Perspektiven erfährst Du in diesem Beitrag.

[…]

  • Klicken, um einem Freund einen Link per E-Mail zu senden (Wird in neuem Fenster geöffnet) E-Mail

https://www.divantis.de/der-wohlfuehlwert-mit-ambitionierten-zielen-bis-2030/

SCAP ETF offers strategic small cap investment approach amid market volatility. Active management, robust selection criteria, and potential trade policy shifts create compelling opportunity for investors. #SmallCap #InvestmentStrategy
Small-cap ETFs emerge as powerful investment strategy in falling rate environment. Active management and domestic focus offer unique opportunities for income-seeking investors navigating economic uncertainty. #Investing #SmallCap
🔍 INSIDER BUY ALERT: Prelude Therapeutics $PRLD
📊 Krishna Vaddi, CEO, purchased 675,000 shares at $0.69 per share, investing $467,438 on March 25, 2025.
Too small of a developmental biotech for me.
Read the full analysis: https://bit.ly/4ccBV2N
#InsiderBuying #TheInsidersFund #PRLD #Biotech #DevelopmentalBiotech #SmallCap #CEOBuying #DrugDevelopment #HealthcareStocks #FinancialAnalysis
Insider Buying 03-28-25 Stagflation is the Game. Confidence has been Shattered

The market as measured by the S&P 500 shed 1.53% last month. The dollar was down, gold up. There seems […]

The Insiders Fund

Video: My Brand New Shiny RRSP Portfolio

I take you on my #journey to getting a brand new shiny #RRSP #portfolio. I choose the #wealthsimple #brokerage, sell my #mutualfunds, and share what #assets I am buying, specifically #index #ETFs covering the #TSX, #SP500, #developed #markets and #emerging #markets. I also get #smallcap #stock #ETF, a #technology ETF and a #bond fund as a #piggybank. The #CanadianMoneyTalk channel concentrates on #Canadianinvesting and…

http://canadianmoneytalk.ca/2025/03/16/video-my-brand-new-shiny-rrsp-portfolio/

Video: My Brand New Shiny RRSP Portfolio

I take you on my #journey to getting a brand new shiny #RRSP #portfolio. I choose the #wealthsimple #brokerage, sell my #mutualfunds, and share what #assets I am buying, specifically #index #ETFs c…

Canadian Money Talk
Ab und an haue ich ja mal was raus zu #Aktien #ETF und #Crypto, bin aber da auch nicht der Fachmann. Ich hangel mich da mit angelesenen Wissen durch. Meine Strategie: 95% in Aktien und #Anleihen ETF und 5% #Spekulation mit Crypto und #SmallCap Werten den ich was zutraue #Börse #Kapitalmarkt
🌟 ASX Small-Caps in the Spotlight: Key Highlights Today!
Southern Cross Gold (ASX: SXG) skyrocketed 18% to $2.95, leading a 4.31% surge in the ASX Gold Index. Resolute Mining (ASX: RSG) shines with a 12.5% gain, riding strong bullish momentum.
Gold is glittering, tech is thriving, and small-cap stocks are bursting with potential. Stay tuned for more market-moving stories!
Visit - https://www.skrillnetwork.com/asx-smallcaps-shine-gold-tech-and-bold-moves-fuel-investor-buzz
#ASX #ASXNEWS #SMALLCAP #Technology
ASX Small-Caps Today: Gold Shines, Life360 CEO’s Bold Move, and Tech Stocks Rally

Discover the latest ASX small-cap updates: Southern Cross Gold surges 18%, Life360 CEO’s strategic sell-off, and Cuscal’s $336.8M IPO plans. Stay informed on top-performing stocks and market trends driving investor interest today